β³ Fetching live dividend data...
Home βΊ Calculator βΊ HQL Dividend Calculator 2026
Tekla Life Sciences Investors Β· NYSE
Price: $17.73 Β· Annual div: $2.24/share Β· Frequency: quarterly Β· Payout ratio: N/A Β· Ex-div: 2026-08-24
HQL (Tekla Life Sciences Investors) has a dividend yield of 12.63%, based on an annual dividend of $2.24 per share and a price of $17.73. Over the last 12 months it paid $2.24 per share β a trailing yield of 12.63%. Dividends are paid quarterly.
Yield history: over the last 12 payments, HQL's 12-month yield ranged from 10.64% to 17.61%. Full HQL dividend history β
Yield on cost: if HQL's dividend keeps growing 6.0% a year, a purchase at today's price would yield 16.91% after 5 years, 22.63% after 10 years and 40.52% after 20 years on the original investment.
With dividends reinvested, a HQL position grows its share count by about 13.39% in the first year at today's price and yield. If the dividend grows 6.0% a year and the price 0.0%, DRIP doubles your number of shares in about 5 years without adding new money.
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
| Ex-Dividend Date | Payment Date | Amount / Share | TTM Yield | Stock Price |
|---|---|---|---|---|
| 2026-08-24Latest | 2026-09-30 | $0.6200 | 11.62% | $19.27 |
| 2026-05-21 | 2026-06-30 | $0.5600 | 14.07% | $17.55 |
| 2026-02-20 | 2026-03-31 | $0.5600 | 13.87% | $17.16 |
| 2025-11-21 | 2026-01-12 | $0.5000 | 10.64% | $17.10 |
| 2025-08-22 | 2025-09-30 | $0.4200 | 17.61% | $13.12 |
| 2025-05-22 | 2025-06-30 | $0.4300 | 14.88% | $12.70 |
| 2025-02-21 | 2025-03-31 | $0.4700 | 13.84% | $14.02 |
| 2024-11-21 | 2025-01-10 | $0.5000 | 12.70% | $14.65 |
| 2024-08-23 | 2024-09-30 | $0.4900 | 10.79% | $15.39 |
| 2024-05-22 | 2024-06-28 | $0.4800 | 13.63% | $13.28 |
| 2024-02-21 | 2024-03-28 | $0.3900 | 11.94% | $13.90 |
| 2023-11-21 | 2024-01-10 | $0.3000 | 13.34% | $11.84 |
| 2023-08-24 | 2023-09-29 | $0.3200 | 11.93% | $13.33 |
| 2023-05-24 | 2023-06-30 | $0.3200 | 11.52% | $14.06 |
| 2023-02-24 | 2023-03-31 | $0.3300 | 8.74% | $14.88 |
| 2022-11-23 | 2022-12-30 | $0.3100 | 9.26% | $14.69 |
| 2022-08-25 | 2022-09-30 | $0.3100 | 12.88% | $14.75 |
| 2022-05-26 | 2022-06-30 | $0.3500 | 12.74% | $15.70 |
| 2022-02-24 | 2022-03-31 | $0.3900 | 11.32% | $18.38 |
| 2021-11-23 | 2021-12-31 | $0.4200 | 9.93% | $21.25 |
| 2021-08-26 | 2021-09-30 | $0.4300 | 10.01% | $20.97 |
| 2021-05-27 | 2021-06-30 | $0.4100 | 9.74% | $20.63 |
| 2021-02-25 | 2021-03-31 | $0.4300 | 9.74% | $20.43 |
| 2020-12-30 | 2021-01-06 | $0.0200 | β | β |
| 2020-11-25 | 2020-12-31 | $0.4000 | β | β |
| 2020-08-27 | 2020-09-30 | $0.4100 | β | β |
| 2020-05-28 | 2020-06-30 | $0.3400 | β | β |
| 2020-02-27 | 2020-03-31 | $0.3900 | β | β |
| 2019-11-26 | 2019-12-31 | $0.3300 | β | β |
| 2019-08-27 | 2019-09-30 | $0.3700 | β | β |
| 2019-05-30 | 2019-06-28 | $0.3700 | β | β |
| 2019-02-27 | 2019-03-29 | $0.3300 | β | β |
| 2018-11-27 | 2018-12-31 | $0.4200 | β | β |
| 2018-08-27 | 2018-09-28 | $0.4000 | β | β |
| 2018-05-31 | 2018-06-29 | $0.4000 | β | β |
| 2018-02-27 | 2018-03-29 | $0.4000 | β | β |
| 2017-11-27 | 2017-12-29 | $0.4300 | β | β |
| 2017-08-24 | 2017-09-29 | $0.4200 | β | β |
| 2017-05-30 | 2017-06-30 | $0.4100 | β | β |
| 2017-02-24 | 2017-03-31 | $0.3600 | β | β |
| 2016-11-23 | 2016-12-30 | $0.4000 | β | β |
| 2016-06-21 | 2016-08-12 | $0.8200 | β | β |
| 2016-04-21 | 2016-06-10 | $0.3700 | β | β |
| 2016-02-26 | 2016-03-31 | $0.4800 | β | β |
| 2015-12-28 | 2016-01-08 | $0.7100 | β | β |
| 2015-11-23 | 2015-12-31 | $0.4700 | β | β |
| 2015-08-26 | 2015-09-30 | $0.5800 | β | β |
| 2015-05-22 | 2015-06-30 | $0.5400 | β | β |
| 2015-02-26 | 2015-03-31 | $0.5000 | β | β |
| 2014-11-24 | 2014-12-31 | $0.4700 | β | β |
| 2014-08-27 | 2014-09-30 | $0.4500 | β | β |
| 2014-05-23 | 2014-06-30 | $0.4300 | β | β |
| 2014-02-27 | 2014-03-31 | $0.4200 | β | β |
| 2013-11-25 | 2013-12-31 | $0.4000 | β | β |
| 2013-08-27 | 2013-09-30 | $0.3500 | β | β |
| 2013-05-23 | 2013-06-28 | $0.3400 | β | β |
| 2013-02-27 | 2013-03-28 | $0.3000 | β | β |
| 2012-11-19 | 2012-12-31 | $0.3100 | β | β |
| 2012-08-20 | 2012-09-28 | $0.3000 | β | β |
| 2012-05-21 | 2012-06-29 | $0.2900 | β | β |
| 2012-02-17 | 2012-03-30 | $0.2600 | β | β |
| 2011-11-17 | 2011-12-30 | $0.2300 | β | β |
| 2011-08-19 | 2011-09-30 | $0.2700 | β | β |
| 2011-05-20 | 2011-06-30 | $0.2600 | β | β |
| 2011-02-16 | 2011-03-31 | $0.2500 | β | β |
| 2010-11-18 | 2010-12-30 | $0.2300 | β | β |
| 2010-08-19 | 2010-09-30 | $0.1300 | β | β |
| 2010-05-20 | 2010-06-30 | $0.1600 | β | β |
| 2009-05-20 | 2009-06-30 | $0.2000 | β | β |
| 2009-02-18 | 2009-03-31 | $0.2200 | β | β |
| 2008-11-19 | 2008-12-31 | $0.2600 | β | β |
| 2008-08-20 | 2008-09-30 | $0.2600 | β | β |
| 2008-05-21 | 2008-06-30 | $0.2700 | β | β |
| 2008-02-20 | 2008-03-31 | $0.3100 | β | β |
| 2007-11-19 | 2007-12-31 | $0.3100 | β | β |
| 2007-08-20 | 2007-09-28 | $0.2900 | β | β |
| 2007-05-23 | 2007-06-29 | $0.2900 | β | β |
| 2007-02-20 | 2007-03-30 | $0.2800 | β | β |
| 2006-11-17 | 2006-12-29 | $0.2800 | β | β |
| 2006-09-06 | 2006-09-29 | $0.2900 | β | β |
Tekla Life Sciences Investors, a closed-ended equity mutual fund, is expertly managed by Tekla Capital Management LLC. This U.S.-domiciled fund, which commenced operations on February 20, 1992, and was formerly known as H&Q Life Sciences Investors, seeks investment opportunities in publicly traded companies worldwide. Its primary focus lies within the broad life sciences sector, encompassing a diverse range of industries such as biotechnology, pharmaceuticals, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, and medical devices and supplies. The fund also extends its investment purview to include the agriculture and environmental management sectors. It predominantly allocates capital to growth-oriented businesses, particularly those with small market capitalizations. Investment decisions are rooted in rigorous fundamental analysis, which assesses critical factors like a company's market position for its offerings, the acumen of its management team, its technological prowess, and its capability to either self-finance expansion or attract external funding to build its portfolio. The fund's performance is gauged against two key benchmarks: the NASDAQ Biotech Index and the S&P 500 Index.
HQL (Tekla Life Sciences Investors) has a dividend yield of 12.63%, based on an annual dividend of $2.24 per share and a price of $17.73. Over the last 12 months it paid $2.24 per share β a trailing yield of 12.63%. Dividends are paid quarterly.
$10,000 in HQL at a 12.63% yield pays about $1,263 a year ($105 a month) before taxes. With DRIP, reinvested dividends buy more shares and that income compounds.
With dividends reinvested, a HQL position grows its share count by about 13.39% in the first year at today's price and yield. If the dividend grows 6.0% a year and the price 0.0%, DRIP doubles your number of shares in about 5 years without adding new money.
Enter your starting amount, monthly contribution and time horizon in the HQL DRIP calculator at the top of this page. It reinvests each payout into new shares at the projected price, grows the dividend at the rate you choose and shows yearly income, share count, portfolio value and yield on cost. You can switch DRIP off to compare.
HQL's next ex-dividend date has not been announced yet; the most recent one was 2026-08-24. HQL pays dividends quarterly. Buy before the ex-dividend date to receive the next payment.
HQL's dividend changed 23.1% over the last year and 5.8% a year on average over five years.
Forward dividend yield from the latest data Β· open any DRIP calculator
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. Β· Privacy Policy
Ready to invest? Open HQL position with:
Real after-tax yield depends on where you live and how you hold HQL.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| πΊπΈ Roth IRA / 401k | 0% | 12.63% | 9.83% | $1,263 / yr |
| πΊπΈ US Taxable (15%) β | 15% | 10.74% | 7.94% | $1,074 / yr |
| πΊπΈ US Taxable (20%) | 20% | 10.10% | 7.30% | $1,010 / yr |
| π¬π§ UK ISA | 0% | 12.63% | 9.83% | $1,263 / yr |
| π¬π§ UK Taxable | 8.75% | 11.52% | 8.72% | $1,152 / yr |
| π¨π¦ TFSA | 0% | 12.63% | 9.83% | $1,263 / yr |
| π¨π¦ CA Taxable | 25% | 9.47% | 6.67% | $947 / yr |
| π¦πΊ Super (pension) | 15% | 10.74% | 7.94% | $1,074 / yr |
| π¦πΊ AU Taxable | 30% | 8.84% | 6.04% | $884 / yr |
| π©πͺ DE Taxable | 26.375% | 9.30% | 6.50% | $930 / yr |
| π«π· FR Taxable | 30% | 8.84% | 6.04% | $884 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.24/share/yr Β· πΊπΈ US Taxable (15%) Β· static projection (no growth assumed).
HQL pays quarterly β 4 times per year. Ex-div: 2026-08-24.
How HQL compares to typical Financial Services averages.
Benchmarks: S&P 500 sector averages (2024β2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for HQL sourced from FMP /financial-growth endpoint β real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| Buy | 2026-07-16 | 527 | $19.92 | $10.5K | ||
| Buy | 2025-12-16 | 7,923 | $16.88 | $133.8K | ||
| Sale | 2025-09-19 | 6,989 | $14.10 | $98.5K | ||
| Sale | 2025-09-22 | 41,623 | $14.14 | $588.5K | ||
| Sale | 2025-09-17 | 24,328 | $13.99 | $340.3K | ||
| Sale | 2025-09-18 | 40,208 | $14.07 | $565.7K | ||
| Sale | 2025-09-15 | 700 | $14.13 | $9.9K | ||
| Sale | 2025-09-16 | 2,026 | $13.99 | $28.3K | ||
| Sale | 2025-09-11 | 15,116 | $14.28 | $215.9K | ||
| Sale | 2025-09-02 | 14,083 | $14.04 | $197.7K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Compare HQL with peers: HQL vs CCAP Β· HQL vs CION Β· HQL vs ECC
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores β lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the HQL dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer β
Tekla Life Sciences Investors (HQL) is currently trading at $17.73, 22% below its 52-week high. The current dividend yield is 12.63% based on an annual payout of $2.24 per share.
Tekla Life Sciences Investors (HQL) is a financial services stock currently trading at $17.73 with a dividend yield of 12.63%. It pays an annual dividend of $2.24 per share. Over the past 5 years, HQL has grown its dividend at a compound annual rate of 5.8%.
Auto-generated from live market data. For educational purposes only β not financial advice.
News aggregated from public sources via Finnhub & RSS. For informational purposes only.
Illustrative examples of common use cases, written by the DividendFlow team β not customer reviews.
| Year | Shares bought by dividends | Total shares | Dividend income | Position value | Yield on cost |
|---|---|---|---|---|---|
| 1 | 75.53 | 639.55 | $1,339 | $11,339 | 13.39% |
| 3 | 109.90 | 840.23 | $1,948 | $14,897 | 19.48% |
| 5 | 164.72 | 1138.97 | $2,920 | $20,194 | 29.20% |
| 10 | 527.15 | 2857.04 | $9,346 | $50,655 | 93.46% |
| 20 | 12743.90 | 44195.73 | $225,949 | $783,590 | 2259.49% |
DRIP rate = share-count growth from reinvested dividends. Simplified yearly model before taxes and fees; adjust every assumption in the calculator above. Not financial advice. How DRIP and the DRIP rate work β
Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.
I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly β $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.
Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.
As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.
The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.
For educational purposes only. Not financial advice.
Share your real experience on Trustpilot βIf DividendFlow helped you see your future dividend income clearly, other investors deserve the same clarity. Your review takes 30 seconds and makes a real difference.
β±οΈ Takes 30 seconds Β· No signup Β· Free forever